Biotech

Prestige Biopharma raises 453 billion won from Korean IPO

SINGAPORE-BASED biotech firm Prestige Biopharma has raised net proceeds of 453 billion won (S$539.9 million) from an initial public offering (IPO) on the Korea Exchange.

Prestige Biopharma eyes at least 1.8t won valuation in Korean IPO

SINGAPORE-BASED Prestige Biopharma expects an implied market capitalisation of between 1.8 trillion won and 1.93 trillion won (S$2.2 billion to S$2.3 billion) in its upcoming initial public...

Near-unicorn Prestige Biopharma eyes early-2021 IPO in South Korea

SINGAPORE-BASED Prestige Biopharma is in the midst of pursuing an initial public offering (IPO) on the Korea Exchange, with a targeted listing in early 2021, the firm's chief executive Lisa Park...

Achieving breakthroughs in cancer treatment

CANCER treatment has made great strides over the years, with conventional ways like chemotherapy gradually making way for progressive ones that hold promise of greater effectiveness.

Rocky road for firms in race for Covid-19 test

SINGAPORE companies are stepping up in the race to produce cheaper and less-invasive Covid-19 testing methods. This comes as demand is expected to surge with the rollout of travel bubbles globally...

Hummingbird gets green light for Covid-19 antibody clinical trial study

BIOTECH startup Hummingbird Biosciences has received approval from Singapore's Health Sciences Authority (HSA) for a clinical trial to study its experimental antibody therapy against SARS-CoV-2,...

Singapore still falling short for home-grown biotechs seeking IPO

HOME-GROWN biotech companies would rather look for opportunities further ashore than list on the Singapore Exchange (SGX). Although the city-state has a growing biotech ecosystem, the local bourse...

Singapore factory output up 13% in April, biomedical manufacturing doubles: EDB

SINGAPORE'S manufacturing output in April increased for a second consecutive month following...

Singapore biotech firm Veredus launches Covid-19 test kit for hospital, lab use

SINGAPORE-BASED biotech firm Veredus Laboratories on Thursday said its coronavirus test has received provisional authorisation from Singapore's Health Sciences Authority for in-vitro diagnostic...

Biotherapeutics startup Hummingbird raises US$19m in Series B funding

SINGAPORE-BASED Hummingbird Bioscience has raised US$19 million in a Series B round co-led by Mirae Asset Venture Investment and GNTech Venture Capital, the startup announced in a press release on...

Engine Biosciences to raise additional funding next year

A BIOTECH startup that only this year raised what is believed to be the largest round of seed funding in South-east Asia has plans to raise additional funding as early as next year, The Business...